CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. China Resources Double-Crane Pharmaceutical Co.,Ltd. Stock
Equities
600062
CNE000000Q94
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.5 CNY | +5.29% |
|
+0.05% | +10.22% |
| 06:17am | CR Double-Crane Pharmaceutical Gets Nod to Trial Semaglutide Injection | MT |
| Mar. 26 | CR Double-Crane Pharma Unit Receives Approval for Epilepsy Drug | MT |
| Sales 2024 * | 11.39B 1.57B | Sales 2025 * | 12.72B 1.76B | Capitalization | 20.93B 2.89B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.52B 210M | Net income 2025 * | 1.72B 237M | EV / Sales 2024 * | 1.84 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.64 x |
| P/E ratio 2024 * |
14
x | P/E ratio 2025 * |
12.4
x | Employees | - |
| Yield 2024 * |
1.46% | Yield 2025 * |
1.66% | Free-Float | 38.65% |
More Fundamentals
* Assessed data
More news
| 1 day | +5.29% | ||
| 1 week | +0.05% | ||
| Current month | -0.82% | ||
| 1 month | -0.77% | ||
| 3 months | +14.27% | ||
| 6 months | +15.10% | ||
| Current year | +10.22% |
1 week
18.93
20.83
1 month
18.9321.49
Current year
15.9421.55
1 year
14.8022.22
3 years
10.9537.44
5 years
10.8637.44
10 years
10.6637.44
| Managers | Title | Age | Since |
|---|---|---|---|
Wen Chao Lu
CHM | Chairman | - | 23-09-20 |
Li Hong Zheng
IRC | Investor Relations Contact | - | - |
Zhiyong Ge
PRN | Corporate Officer/Principal | 61 | 06-06-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mao Zhu Sun
BRD | Director/Board Member | 65 | 21-07-11 |
Ning Liu
BRD | Director/Board Member | 66 | 06-05-29 |
Wei Zheng
BRD | Director/Board Member | 64 | 18-06-21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-15 | 20.5 | +5.29% | 17,656,730 |
| 24-04-12 | 19.47 | -1.86% | 22,159,280 |
| 24-04-11 | 19.84 | -2.65% | 14,294,420 |
| 24-04-10 | 20.38 | -1.36% | 5,876,115 |
| 24-04-09 | 20.66 | +0.83% | 6,409,215 |
End-of-day quote Shanghai S.E., April 14, 2024
More quotes
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the development, manufacture and distribution of pharmaceuticals. The Company's main businesses are classified into three segments: Chronic Disease segment, Specialist segment and Infusion segment. Chronic Disease segment mainly provides products for lowering blood pressure, blood fat and blood glucose. Specialist segment mainly involves in the research, development and distribution of pharmaceuticals targeting six areas, including cardiovascular and cerebrovascular, pediatrics, kidney disease, mental/nerve, anesthesia and analgesia and respiratory areas. Infusion segment various types of infusion products, such as basic infusion, therapeutic infusion and nutritional. The Company distributes its products mainly in domestic market.
Sector
Pharmaceuticals
Calendar
2024-04-25
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
20.5
CNY
Average target price
24.91
CNY
Spread / Average Target
+21.53%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +10.22% | 2.89B | |
| +28.54% | 676B | |
| +24.31% | 559B | |
| -6.78% | 356B | |
| +15.29% | 320B | |
| +5.23% | 286B | |
| +2.91% | 213B | |
| +0.22% | 207B | |
| -9.53% | 199B | |
| -7.92% | 142B |
- Stock Market
- Equities
- 600062 Stock
